Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Temporal Stability and Prognostic Biomarker Potential of the Prostate Cancer Urine miRNA Transcriptome.

Autor: Jeon J; Ontario Institute for Cancer Research, Toronto, ON, Canada., Olkhov-Mitsel E; Lunenfeld-Tannenbaum Research Institute, Sinai Health System, Toronto, ON, Canada., Xie H; Ontario Institute for Cancer Research, Toronto, ON, Canada., Yao CQ; Ontario Institute for Cancer Research, Toronto, ON, Canada., Zhao F; Lunenfeld-Tannenbaum Research Institute, Sinai Health System, Toronto, ON, Canada., Jahangiri S; Sunnybrook Research Institute and Department of Radiation Oncology, Sunnybrook-Odette Cancer Centre, Toronto, ON, Canada., Cuizon C; Lunenfeld-Tannenbaum Research Institute, Sinai Health System, Toronto, ON, Canada., Scarcello S; Sunnybrook Research Institute and Department of Radiation Oncology, Sunnybrook-Odette Cancer Centre, Toronto, ON, Canada., Jeyapala R; Lunenfeld-Tannenbaum Research Institute, Sinai Health System, Toronto, ON, Canada., Watson JD; Ontario Institute for Cancer Research, Toronto, ON, Canada., Fraser M; Ontario Institute for Cancer Research, Toronto, ON, Canada., Ray J; Sunnybrook Research Institute and Department of Radiation Oncology, Sunnybrook-Odette Cancer Centre, Toronto, ON, Canada., Commisso K; Sunnybrook Research Institute and Department of Radiation Oncology, Sunnybrook-Odette Cancer Centre, Toronto, ON, Canada., Loblaw A; Sunnybrook Research Institute and Department of Radiation Oncology, Sunnybrook-Odette Cancer Centre, Toronto, ON, Canada., Fleshner NE; Princess Margaret Cancer Centre, University Health Network, Toronto, ON, Canada., Bristow RG; Princess Margaret Cancer Centre, University Health Network, Toronto, ON, Canada.; Department of Medical Biophysics, University of Toronto, Toronto, ON, Canada.; Manchester Cancer Research Centre, University of Manchester, Manchester, UK., Downes M; Ontario Institute for Cancer Research, Toronto, ON, Canada., Vesprini D; Sunnybrook Research Institute and Department of Radiation Oncology, Sunnybrook-Odette Cancer Centre, Toronto, ON, Canada., Liu S; Sunnybrook Research Institute and Department of Radiation Oncology, Sunnybrook-Odette Cancer Centre, Toronto, ON, Canada.; Department of Medical Biophysics, University of Toronto, Toronto, ON, Canada., Bapat B; Lunenfeld-Tannenbaum Research Institute, Sinai Health System, Toronto, ON, Canada.; Department of Laboratory Medicine and Pathobiology, University of Toronto, Toronto, ON, Canada., Boutros PC; Ontario Institute for Cancer Research, Toronto, ON, Canada.; Department of Medical Biophysics, University of Toronto, Toronto, ON, Canada.; Department of Pharmacology & Toxicology, University of Toronto, Toronto, ON, Canada.; Department of Human Genetics, University of California, Los Angeles, Los Angeles, CA.; Department of Urology, University of California, Los Angeles, Los Angeles, CA.; Broad Stem Cell Research Centre, University of California, Los Angeles, Los Angeles, CA.; Institute for Precision Health, University of California, Los Angeles, Los Angeles, CA.; Jonsson Comprehensive Cancer Center, University of California, Los Angeles, Los Angeles, CA.

Publikováno v: Journal of the National Cancer Institute [J Natl Cancer Inst] 2020 Mar 01; Vol. 112 (3), pp. 247-255.